By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

EpimAb Biotherapeutics 

Gartenstra├če 8

Warmsroth    55442  Germany
Phone: 49-0-15226107621 Fax: n/a


SEARCH JOBS

EpimAb Biotherapeutics is a privately owned biopharmaceutical company dedicated to generating novel bi-specific antibody therapeutics based on its proprietary FIT-Ig (Fabs-In-Tandem) platform.

Monoclonal antibodies have transformed the treatment of human diseases, including inflammatory and autoimmune diseases, cancer, severe infections and many rare conditions over the course of the past two decades. Bi-specific antibodies are engineered from two different monoclonal antibodies and combine their key features into one molecule.

YEAR FOUNDED:

February 2015

LEADERSHIP:

CEO: Chengbin Wu, Ph.D

CBO: Dr. Stephan Lensky

SCIENCE:

Please click here for EpimAb's technology.


Key Statistics


Email:
Ownership: Private

Web Site: EpimAb Biotherapeutics
Employees:
Symbol: 
 









Company News
//-->